Chemical and Pharmaceutical Bulletin p. 867 - 870 (1998)
Update date:2022-08-05
Topics:
Asagarasu, Akira
Takayanagi, Nao
Achiwa, Kazuo
Some dipeptide-type human immunodeficiency virus (HIV) protease inhibitors derived from KNI-102, with a N-carbomethoxycarbonylprolyl- phenylalanine benzyl ester (CPF) moiety as a binding site to gp120, were synthesized. Compounds 11a showed 7 - 100 times higher HIV protease- inhibitory activity (11a; IC50 = 0.90 μg/ml, 1.1 μM) than the standard compound 3 or 4 (3; IC50 = 3.7 μg/ml, 7.7 μM, 4; IC50 = 75 μg/ml, 155 μM). Generally, the compounds substituted at the o-position of the phenoxyacetyl group 7a, 11a, 16a and 21a showed several times higher inhibitory activity than 3.
View MoreChuzhou Baiao Biologhy S&T Co., Ltd.
Contact:+86-25-83212599；+86-25-83212699 13705185959
Address:Room 905, Tianzheng International Platza, No.399, Zhongyang Road ,Nanjing, Jiangsu Province, China
website:http://www.apeptides.com/en/
Contact:+86-21-60871011
Address:No. 80 Chuanshan Shuyuan Steet,Pudong,Shanghai
Taizhou KEDE Chemical.Co.,Ltd.
Contact:86-576-84613060
Address:Jiangkou Chemical Zoon
Contact:+86-25-85281586
Address:13F,Bld2#,South of Longpan Road
Changzhou Sunlight Pharmaceutical Co., Ltd.
Contact:+86-519-83131668;83139028;83138042;83137041
Address:JiuliStreet, Benniu Town Changzhou City, Jiangsu Province
Doi:10.1016/S0008-6215(97)10082-9
(1998)Doi:10.1021/ol025909w
(2002)Doi:10.1002/ejoc.201301468
(2014)Doi:10.1016/S0040-4039(00)60395-7
(1993)Doi:10.1016/S0960-894X(98)00215-7
(1998)Doi:10.1021/ja9803411
(1998)
